Ocugen Inc (OCGN)
0.9386
-0.06
(-6.14%)
USD |
NASDAQ |
Nov 15, 16:00
0.951
+0.01
(+1.32%)
After-Hours: 20:00
Ocugen Research and Development Expense (TTM): 33.34M for Sept. 30, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| September 30, 2024 | 33.34M |
| June 30, 2024 | 31.57M |
| March 31, 2024 | 37.25M |
| December 31, 2023 | 40.59M |
| September 30, 2023 | 54.70M |
| June 30, 2023 | 63.98M |
| March 31, 2023 | 58.42M |
| December 31, 2022 | 56.16M |
| September 30, 2022 | 39.65M |
| June 30, 2022 | 30.30M |
| March 31, 2022 | 40.15M |
| December 31, 2021 | 35.11M |
| September 30, 2021 | 29.60M |
| June 30, 2021 | 24.80M |
| March 31, 2021 | 7.574M |
| December 31, 2020 | 6.354M |
| September 30, 2020 | 6.508M |
| June 30, 2020 | 6.335M |
| March 31, 2020 | 5.151M |
| December 31, 2019 | 5.082M |
| September 30, 2019 | 6.662M |
| Date | Value |
|---|---|
| June 30, 2019 | 9.919M |
| March 31, 2019 | 13.93M |
| December 31, 2018 | 15.63M |
| September 30, 2018 | 15.67M |
| June 30, 2018 | 14.60M |
| March 31, 2018 | 14.35M |
| December 31, 2017 | 15.57M |
| September 30, 2017 | 17.52M |
| June 30, 2017 | 18.91M |
| March 31, 2017 | 20.50M |
| December 31, 2016 | 21.58M |
| September 30, 2016 | 22.03M |
| June 30, 2016 | 23.00M |
| March 31, 2016 | 23.06M |
| December 31, 2015 | 23.24M |
| September 30, 2015 | 22.23M |
| June 30, 2015 | 29.62M |
| March 31, 2015 | 28.43M |
| December 31, 2014 | 26.04M |
| September 30, 2014 | 24.82M |
| June 30, 2014 | 15.14M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
5.082M
Minimum
Dec 2019
63.98M
Maximum
Jun 2023
30.63M
Average
32.46M
Median
Research and Development Expense (TTM) Benchmarks
| Cytokinetics Inc | -- |
| Scholar Rock Holding Corp | 169.15M |
| Mirum Pharmaceuticals Inc | 121.95M |
| SpringWorks Therapeutics Inc | 179.09M |
| NeuroBo Pharmaceuticals Inc | 21.36M |